Indication of Anti-HBc antibody screening and HBV-DNA detection in diagnosing latent hepatitis B virus infection

Iranian Journal of Medical Sciences

Volumn 30, Issue 1, 2005, Pages 28-33

  Behzad Behbahani, Abbas ^a,e   Mafi Nejad, A ^a   Tabei, S Z ^a   Lankarani, K B ^b   Rashidi, M ^c   Rasouli, M ^c   Pourabbas, B ^c   Torab, A ^d   Salah, A R ^d  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti HBc; Blood donors; HBV DNA; Hepatitis B virus infection; Iran

Indexed keywords

HEPATITIS B CORE ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; DNA DETERMINATION; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS B; HUMAN; IRAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION;

EID: 25844459747     PISSN: 02530716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334: 1685-90.
2. Saraswat S, Banerjee K, Chaudhury N, et al. Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol 1996; 25: 639-43.
3. Jongerius JM, Wester M, Cuypers HT, et al. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 1998; 38: 56-9.
4. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997; 4: S11-S20.
5. Carman WF, Mimms LT. Pre-S/S gene variants of hepatitis B virus. In Rizetto M, Purcell RH, Gerin JL, Verne G, editors. Viral hepatitis and liver disease. Edizioni Minerva Medica; Torino, Italy; 1997. p. 108-15.
6. Tsai S, Liaw Y, Yeh C, Chu C, Kuo GC. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: Dominant role of hepatitis C virus. Hepatology 1995; 21: 908-12.
7. Lee WM. Hepatitis B virus infection: N Engl J Med 1997; 337: 1733-45.
8. Ben Ayed M, Triki H, Cointe D, et al. The isolated presence of anti-HBc antibodies: prevalence and interpretation based on the results of viral DNA research and anti-HBs antibodies measurement after vaccination. Ann Biol Clin (Paris) 2001; 59: 53-60.
9. Gomes SA, Yoshida CF, Niel C. Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum by polymerase chain reaction: evaluation of different primer pairs and conditions. Acta Virol 1996; 40: 133-8.
10. Iizuka H, Ohmura K, Ishijima A, et al. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992; 63: 107-11.
11. Zervou EK, Dalekos GN, Boumba DS, Tsianos EV. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion 2001;41:652-8.
12. Malekzadeh R, Khatibian M, Rezvan H: Viral hepatitis in the world and Iran. J Iran Med Concil. 1997; 15: 183-200.
13. Merat Sh, Malekzadeh R, Rezvan h, Khatibian M. Hepatitis B in Iran. Arch Iranian Med 2000; 3: 192-201.
14. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg 1993; 96: 277-87.
15. Kwok S, Higushi R. Avoiding false positives with PCR. Nature 1989; 339: 237-8.
16. Gish RG, Lau JY, Brooks L, et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996; 23: 1-7.
17. Bernvil SS, Andrews V, Kuhns MC, McNamara AL. Hepatitis B core antigen antibody as an indicator of a low-grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population. Transfus Sci 1997; 18: 49-53.
18. Torii N, Hasegawa K, Joh R, Hayashi N. Configuration and replication competence of hepatitis B virus DNA in peripheral blood mononuclear cells from chronic hepatitis B patients and patients who have recovered from acute self-limited hepatitis. Hepatol Res 2003; 25: 234-43.
19. Brechot C, Thiers V, Kremsdorf D, et al. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001; 34: 194-203.
20. Hennig H, Puchta I, Luhm J, et al. Frequency and load of hepatitis B virus DNA in first time blood donors with antibodies to hepatitis B core antigen. Blood 2002; 100: 2637-41.
21. Roche B, Feray C, Gigou M, et al. DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis. Hepatology 2003; 38: 86-95.
22. Seddigh-Tonekaboni S, Waters JA, Jeffers S, et al. Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 2000; 60: 113-21.
23. Malekzadeh R, Mohamadnejad M, Rakhshani, et al. Reversibility of cirrhosis in chronic hepatitis B. Clin Gastroenterol Hepatol 2004; 2: 344-7.
24. Nandi J, Benerjee K. detection of hepatitis B virus DNA in donor blood by polymerase chain reaction. Natl Med J India 1992; 5: 5-7.